The Importance of FDA Oversight in Reproductive HCT/Ps

FDA oversight of HCT/P facilities impacts patient safety and the integrity of regenerative medicine and cellular therapies. By requiring compliance of laboratories handling reproductive donor tissues (sperm, egg, and embryos), the purpose of federal regulations they enforce reduces the risk of communicable disease transmission to future parents.